Caregiver Economic Burden
The economic cost of ME/CFS extends beyond the patient to family members who reduce their own work hours, leave the workforce, or become informal caregivers — often without compensation, training, or support.
Brittain et al. (2021), using the FROM-16 family impact tool, found that 87% of family members of ME/CFS patients reported moderate-to-severe impact on their own quality of life, and 50.2% reported reduced family income following the patient’s diagnosis (Brittain et al. 2021). The Australian cost-of-illness studies include informal care in their indirect cost estimates — the cost of care provided by family members who could otherwise be working (Zhao et al. 2023) (Close et al. 2020). However, no study has produced a standalone monetary valuation of ME/CFS caregiver burden using established health-economic methods (willingness-to-pay, replacement-cost, or opportunity-cost valuation). (Certainty: 0.55 — single family-impact study; n=68 patients + 118 family members; FROM-16 validated but not ME/CFS-specific; no monetary caregiver valuation exists.)
Consequence: The caregiver burden is simultaneously the most visible (every patient and family knows it) and the least quantified dimension of ME/CFS economics. The 50.2% income-reduction figure means that ME/CFS often impoverishes two people per patient — the patient and the primary caregiver. This has implications for disability benefit design: a system that assesses only the patient’s functional capacity ignores the caregiver’s lost income and the household-level economic destruction. Severity applicability: caregiver burden scales with patient severity — a caregiver for a very severe patient provides near-constant care; a caregiver for a mild patient may face only reduced household productivity.